Clin2
NCT03472157Possibly a fitRecruiting

Bariatric surgery for severe NASH with advanced liver scarring

SurgeryObesityNASH - Nonalcoholic SteatohepatitisCirrhosis

Part of Digestive system, Hormones & metabolism clinical trials.

This study tests whether bariatric surgery (either sleeve gastrectomy or Roux-en-Y gastric bypass) improves severe nonalcoholic steatohepatitis (NASH) with advanced liver scarring in people who are obese. You may also need liver biopsies to confirm your liver disease before and after treatment.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
100 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You can sign informed consent and follow the study plan and visit schedule
  • You have NASH with advanced liver scarring (F3 or F4) confirmed by FibroScan and/or a liver biopsy
  • You agree to have a liver biopsy during screening and another liver biopsy at the end of treatment
  • Your body weight matches the study: BMI must be at least 30, with specific ranges based on F3 vs F4
  • If you have cirrhosis, blood tests and liver function scores must be within limits (and certain complications must be absent)
  • You must be able to safely have only sleeve gastrectomy or Roux-en-Y gastric bypass

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04232566Recruiting
Study links in obesity surgery and liver scarring

This study looks at how the immune system relates to liver scarring in people with obesity who are getting gastric bypass surgery. If you qualify, you may help doctors better understand liver disease and who is at higher risk.

Scottsdale, Arizona
NCT06374875Recruiting· Phase 4
Does metabolic surgery reduce liver scarring?

This study tests if weight loss surgery can improve liver fibrosis (scarring) in people with obesity and advanced liver disease. It may help those considering surgery to know if their liver health can get better.

Phoenix, Arizona
NCT07760909Not yet recruiting
Metabolic study for fatty liver disease in bariatric surgery patients

This study looks at how the body processes energy in people with fatty liver disease who are having weight-loss surgery. It may help doctors understand the disease better and could lead to better treatments.

NCT02933554Not yet recruiting
Bariatric embolization for nonalcoholic steatohepatitis

This trial tests a procedure called bariatric embolization, which uses tiny particles to block blood flow to part of the stomach, to help you lose weight and reduce liver inflammation from NASH. It might be an option if you have NASH and have not been able to lose weight with diet and exercise alone.

St Louis, Missouri
NCT06625762Recruiting
Nantes bariatric surgery study

This study follows people who are preparing for bariatric (weight-loss) surgery to see how the surgery affects their health over time. It is being done to better understand the benefits and risks of bariatric surgery.

Nantes, Loire-Atlantique
NCT04841057Enrolling by invitation
Study of blood and stool changes after weight-loss surgery

This study looks at how your body’s metabolism changes after a specific weight-loss surgery (gastric bypass). It may help researchers better understand what to expect and how to tailor care, while requiring blood draws and stool samples before and after surgery.

Columbia, Missouri

Hear when a new Obesity trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.